Computer Vision AG

Computer Vision Ltd. (Emeralgo) is a Swiss AI software company specializing in automated interpretation of musculoskeletal MRI scans. Founded in 2016 as a research partnership with Swiss hospitals and radiologists, the company was formally incorporated in Zurich in 2022. Emeralgo delivers FDA 510(k)-cleared AI diagnostic software for quantitative analysis of lumbar spine MRI studies, with planned expansion to knee, shoulder, and hip modules in 2027. The platform performs automated vertebral body measurements, fracture detection, foraminal stenosis assessment, disk degeneration quantification, and spinal canal stenosis analysis. Emeralgo integrates seamlessly into existing hospital PACS and radiological workflows without protocol modifications, requires no operator training, and deploys locally or in the cloud within 30 minutes. The software generates comprehensive, editable diagnostic reports with visual and text information delivered via standard DICOM without additional server infrastructure. Clinical validation includes peer-reviewed publications in Skeletal Radiology, Investigative Radiology, and European Radiology covering meniscus tear detection, ACL detection, vertebral measurements, and spinal stenosis assessment. Compatible with all major MRI manufacturers and common scan protocols. Supported by 200+ Swiss shareholders and staffed by 15 data scientists and AI engineers with 20+ years experience in medical imaging.